logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Beijing Tsinghua Changgeng Hospital

Verified

Basic Information

Site Overview

Source: Human-provided.

Beijing Tsinghua Changgung Hospital is a large-scale comprehensive public hospital affiliated with Tsinghua University and jointly managed by Tsinghua University and the Beijing Municipal Administration of Hospitals. Located in Tiantongyuan, Changping District, Beijing, the hospital opened in 2014 and has a planned capacity of 1,500 beds. It provides services across more than 50 clinical and medical specialty departments, with key centers in hepatobiliary and pancreatic diseases, organ transplantation, cardiovascular medicine, digestive diseases, neurology, infectious diseases, critical care, and oncology. The hospital is also an academic and clinical research institution, serving as a national clinical trial institution for drugs and medical devices and supporting medical education, innovation, and international research collaborations.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
221Total Trials
Source: Trial-derived.
72Recruiting Trials
Source: Trial-derived.
131Active Trials
Source: Trial-derived.
67Completed Trials
Source: Trial-derived.
271Unique Conditions
Source: Trial-derived.
252Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Hepatocellular Carcinoma (7)Source: Trial-derived. Atrial Fibrillation (5)Source: Trial-derived. Choledochal Cyst (4)Source: Trial-derived. Hepatocellular Carcinoma (HCC) (4)Source: Trial-derived. Obesity (4)Source: Trial-derived. Overweight (4)Source: Trial-derived. Acute Kidney Injury (3)Source: Trial-derived. Atopic Dermatitis (3)

Sponsors

Source: Trial-derived. Beijing Tsinghua Chang Gung Hospital (69)Source: Trial-derived. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (9)Source: Trial-derived. Beijing Tsinghua Changgeng Hospital (8)Source: Trial-derived. Boehringer Ingelheim (8)Source: Trial-derived. Beijing Tiantan Hospital (7)Source: Trial-derived. Eli Lilly and Company (5)Source: Trial-derived. Peking University First Hospital (5)Source: Trial-derived. Bayer (4)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. MRI proton density fat fraction
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Dialysis
Source: AI-inferred. Endoscopy / colonoscopy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Clostridioides difficile toxin / stool pathogen testing
Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. Interactive web response system (IWRS)
Source: AI-inferred. Magnetic resonance elastography
Source: AI-inferred. Renal biopsy
Source: AI-inferred. Serum galactose-deficient IgA1 (Gd-IgA1) assay
Source: AI-inferred. Wearable digital health activity monitoring